Vistagen Email Format

Pharmaceutical ManufacturingCalifornia, United States51-200 Employees

Vistagen is a late clinical-stage biopharmaceutical company in the pharmaceutical manufacturing sector, headquartered in South San Francisco, California, with a workforce of 51 to 200 employees. The company develops intranasal product candidates known as pherines, which are designed to selectively activate receptors on nasal chemosensory neurons to engage olfactory bulb-to-brain neurocircuits that influence behavior and autonomic nervous system activity, without systemic blood absorption or brain uptake. Its therapeutic focus includes indications such as social anxiety disorder, major depressive disorder, and various menopausal women's health conditions, including vasomotor symptoms. Vistagen trades on the Nasdaq under ticker VTGN, reflecting its status as a public company. The company's stated aim is to develop and commercialize pherine-based intranasal products for these underserved indications.

Sign up for free to view info

Company overview Employee directory